Hilda Frederique Scharen-Guivel - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Hilda Frederique Scharen-Guivel has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $285K.
Profile
Hilda Frederique Scharen-Guivel is Director at IRADIMED CORP (IRMD). Scharen-Guivel has reported 5 insider filings with the SEC since 2024. The most recent filing was in June 2026.
| Role | Director |
|---|---|
| Notability | 26/100 |
Board memberships
- IRADIMED CORP
Reported roles
- Director
Trading Pattern
InsiderAlpha's records for Hilda Frederique Scharen-Guivel go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Hilda Frederique Scharen-Guivel has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at IRADIMED CORP (IRMD) - 1 filing, 2026
- Insider at IRADIMED CORP (IRMD) - 4 filings, 2024 to 2025
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | IRMD | IRADIMED CORP | S - Open-market sale | 1.2K | $95.00 | $117K |
| 2026-06-04 | IRMD | IRADIMED CORP | S - Open-market sale | 1.8K | $95.00 | $168K |
| 2025-10-14 | IRMD | IRADIMED CORP | M - Option exercise | 1.8K | - | |
| 2024-12-10 | IRMD | IRADIMED CORP | M - Option exercise | 1.2K | - | |
| 2024-10-15 | IRMD | IRADIMED CORP | M - Option exercise | 1.8K | - |
Companies - Last 90 Days
- IRADIMED CORP (IRMD) - 1 filing, last 2026-06-04
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Hilda Frederique Scharen-Guivel has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Roger E. Susi - $14.90M of IRMD open-market activity in the last 12 months
- John Glenn - $900K of IRMD open-market activity in the last 12 months
- James B. Hawkins - $265K of IRMD open-market activity in the last 12 months
- Monty K. Allen - $176K of IRMD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Michael Ho
- David Henry Hoffmann
- Gregg R. Honigblum
- HORIZON KINETICS ASSET MANAGEMENT LLC
- HRT FINANCIAL LP
- HRTG GPE, LLC
- Jack Jiajia Huang
- IAC Inc.
Frequently Asked Questions
Who is Hilda Frederique Scharen-Guivel?
Hilda Frederique Scharen-Guivel is Director at IRADIMED CORP (IRMD). Scharen-Guivel has reported 5 insider filings with the SEC since 2024. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Hilda Frederique Scharen-Guivel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Hilda Frederique Scharen-Guivel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($285K) across all tracked filings.
Where can I see all of Hilda Frederique Scharen-Guivel's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Hilda Frederique Scharen-Guivel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.